Nonviability of cells with oxidative defects in galactose medium: a screening test for affected patient fibroblasts
- PMID: 1329873
- DOI: 10.1016/0885-4505(92)90056-5
Nonviability of cells with oxidative defects in galactose medium: a screening test for affected patient fibroblasts
Abstract
Diagnosis of respiratory chain defects in cultured skin fibroblasts is a difficult diagnostic procedure. We investigated the feasibility of using survival of skin fibroblasts in culture medium with galactose as the major carbon source as a method of quickly diagnosing cell lines that were compromised in oxidative metabolism. We found that cells from patients with most forms of cytochrome oxidase deficiency, cells with complex I deficiency, cells with multiple respiratory chain defects and cells with severe pyruvate dehydrogenase (PDH) complex deficiency failed to survive when subcultured into galactose (5 mM) medium. Cells from patients with Lebers hereditary optic neuropathy (LHON), Kearns-Sayre syndrome (KSS), myoclonus-epilepsy-lactic acidosis-stroke (MELAS), the hepatic form of cytochrome oxidase deficiency, and mild PDH complex deficiency survived well in galactose (5 mM)-containing medium. This could be used as a rapid screening test for skin fibroblasts with major oxidative defects.
Similar articles
-
Selective galactose culture condition reveals distinct metabolic signatures in pyruvate dehydrogenase and complex I deficient human skin fibroblasts.Metabolomics. 2019 Feb 28;15(3):32. doi: 10.1007/s11306-019-1497-2. Metabolomics. 2019. PMID: 30830487
-
Pyruvate dehydrogenase complex deficiency and altered respiratory chain function in a patient with Kearns-Sayre/MELAS overlap syndrome and A3243G mtDNA mutation.J Neurol Sci. 1998 May 7;157(2):206-13. doi: 10.1016/s0022-510x(98)00068-9. J Neurol Sci. 1998. PMID: 9619647
-
Rescue from galactose-induced death of Leigh Syndrome patient cells by pyruvate and NAD.Cell Death Dis. 2018 Nov 14;9(11):1135. doi: 10.1038/s41419-018-1179-4. Cell Death Dis. 2018. PMID: 30429455 Free PMC article.
-
The expanding clinical spectrum of mitochondrial diseases.Brain Dev. 1993 Jan-Feb;15(1):1-22. doi: 10.1016/0387-7604(93)90002-p. Brain Dev. 1993. PMID: 8338207 Review.
-
Cell culture studies on patients with mitochondrial diseases: molecular defects in pyruvate dehydrogenase.J Bioenerg Biomembr. 1988 Jun;20(3):313-23. doi: 10.1007/BF00769635. J Bioenerg Biomembr. 1988. PMID: 3136149 Review.
Cited by
-
Treatment of CoQ(10) deficient fibroblasts with ubiquinone, CoQ analogs, and vitamin C: time- and compound-dependent effects.PLoS One. 2010 Jul 30;5(7):e11897. doi: 10.1371/journal.pone.0011897. PLoS One. 2010. PMID: 20689595 Free PMC article.
-
Mitochondrial respiration restricts Listeria monocytogenes infection by slowing down host cell receptor recycling.Cell Rep. 2021 Nov 9;37(6):109989. doi: 10.1016/j.celrep.2021.109989. Cell Rep. 2021. PMID: 34758302 Free PMC article.
-
Cross-species analysis identifies mitochondrial dysregulation as a functional consequence of the schizophrenia-associated 3q29 deletion.Sci Adv. 2023 Aug 18;9(33):eadh0558. doi: 10.1126/sciadv.adh0558. Epub 2023 Aug 16. Sci Adv. 2023. PMID: 37585521 Free PMC article.
-
Multiomic Profiling of Tyrosine Kinase Inhibitor-Resistant K562 Cells Suggests Metabolic Reprogramming To Promote Cell Survival.J Proteome Res. 2019 Apr 5;18(4):1842-1856. doi: 10.1021/acs.jproteome.9b00028. Epub 2019 Feb 21. J Proteome Res. 2019. PMID: 30730747 Free PMC article.
-
The Metabolic Map into the Pathomechanism and Treatment of PGM1-CDG.Am J Hum Genet. 2019 May 2;104(5):835-846. doi: 10.1016/j.ajhg.2019.03.003. Epub 2019 Apr 11. Am J Hum Genet. 2019. PMID: 30982613 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources